Weighted Average Number of Shares Outstanding, Diluted of Accelerate Diagnostics, Inc from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Accelerate Diagnostics, Inc annual and quarterly Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 31 Dec 2019 to 31 Dec 2024.
  • Accelerate Diagnostics, Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Jun 2024 was 23,058,000, a 109% increase year-over-year.
  • Accelerate Diagnostics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 23,302,000, a 87% increase from 2023.
  • Accelerate Diagnostics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 12,477,000, a 52% increase from 2022.
  • Accelerate Diagnostics, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 8,216,000, a 33% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

Accelerate Diagnostics, Inc Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 23,302,000 +10,825,000 +87% 01 Jan 2024 31 Dec 2024 10-K 21 Mar 2025 2024 FY
2023 12,477,000 +4,261,000 +52% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
2022 8,216,000 +2,043,000 +33% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 6,173,000 -49,837,000 -89% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2024 2023 FY
2020 56,010,000 +1,504,000 +2.8% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2023 2022 FY
2019 54,506,000 01 Jan 2019 31 Dec 2019 10-K 14 Mar 2022 2021 FY

Accelerate Diagnostics, Inc Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 23,058,000 +12,049,000 +109% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 19,216,000 +9,386,000 +95% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 12,477,000 +4,261,000 +52% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q3 2023 14,553,000 +5,852,000 +67% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 11,009,000 +3,386,000 +44% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 9,830,000 -57,925,000 -85% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 8,216,000 +2,043,000 +33% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 8,701,000 -52,445,000 -86% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 7,623,000 -53,426,000 -88% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 67,755,000 +9,235,000 +16% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 6,173,000 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2024 2023 FY
Q3 2021 61,146,000 +4,586,000 +8.1% 01 Jul 2021 30 Sep 2021 10-Q/A 03 Mar 2023 2022 Q3
Q2 2021 61,049,000 +5,604,000 +10% 01 Apr 2021 30 Jun 2021 10-Q/A 03 Mar 2023 2022 Q2
Q1 2021 58,520,000 01 Jan 2021 31 Mar 2021 10-Q/A 03 Mar 2023 2022 Q1
Q3 2020 56,560,000 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 55,445,000 01 Apr 2020 30 Jun 2020 10-Q 11 Aug 2021 2021 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.